Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
January 8, 2025
EBV-specific T-cell immunity: relevance for multiple sclerosis
Malina Behrens, Manuel Comabella, Jan D Lünemann
Annals of Neurology
|
June 18, 2026
Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis
Malina Behrens, Paula Terroba-Navajas, Eline A J Willemse, et al.
Journal of Cell Science
|
January 24, 2024
PALS1 is a key regulator of the lateral distribution of tight junction proteins in renal epithelial cells
Ann-Christin Groh, Annika Möller-Kerutt, Kevin Gilhaus, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study
Frauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner, et al.
Journal of Neurology
|
December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Manuel Comabella, Harald Hegen, Luisa M Villar, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
January 8, 2025
EBV-specific T-cell immunity: relevance for multiple sclerosis
Malina Behrens, Manuel Comabella, Jan D Lünemann
Annals of Neurology
|
June 18, 2026
Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis
Malina Behrens, Paula Terroba-Navajas, Eline A J Willemse, et al.
Journal of Cell Science
|
January 24, 2024
PALS1 is a key regulator of the lateral distribution of tight junction proteins in renal epithelial cells
Ann-Christin Groh, Annika Möller-Kerutt, Kevin Gilhaus, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
November 27, 2024
Ravulizumab and Efgartigimod in Myasthenia Gravis: A Real-World Study
Frauke Stascheit, Carla Daiane Ferreira de Sousa, Annette Aigner, et al.
Journal of Neurology
|
December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Manuel Comabella, Harald Hegen, Luisa M Villar, et al.
Page
of 1